SKINSIGHTS 2026

At Cynosure Lutronic, we believe that, in order to continue leading in the world of energy-based devices, we must understand what patients think, feel and want. This is the driving force behind Skinsights.

Skinsights 2026 is our third annual patient study, and the largest so far.

We surveyed 5,400 consumers aged 18 to 65 across Germany, Spain, Russia, Saudi Arabia and the UK. Nobody was pre-screened on whether they had ever considered treatment, so what came back was a true representation of the population.

Out of everything we found, one thing was clear: aesthetics is now mainstream.
Discover more about the language patients use, their perceptions of the industry and what treatments they’re more likely to consider. Inside, you’ll find:

• Why 67.6% of consumers prefer treatments without needles, and why 71.5% of people who have already had Botox or fillers say the same
• What GLP-1 medications have done to the laxity conversation, now blamed for sagging skin more often than pregnancy
• How the 25 to 34 age bracket is the most in-market age group in the study (and the one thinking furthest ahead)
• Where men fit into aesthetics, and why the industry historically has talked to them in the wrong way
• Six practical takeaways for EMEA clinics

Get under the skin of your patients.

Download Skinsights 2026 today by completing the form.